Klin Monbl Augenheilkd 2022; 239(04): 531-533
DOI: 10.1055/a-1766-6623
Der interessante Fall

Long-Term Efficacy of Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization in a Case of Fundus Flavimaculatus (FFM)

Langzeitige Effektivität der intravitrealen Anti-VEGF-Injektionstherapie chorioidaler Neovaskularisationen bei einem Patienten mit Fundus flavimaculatus (FFM)
Ioanna Zygoula
Dept. of Ophthalmology, Pallas Kliniken, Olten, Switzerland
,
Lars Hefner
Dept. of Ophthalmology, Pallas Kliniken, Olten, Switzerland
,
Heinrich Gerding
Dept. of Ophthalmology, Pallas Kliniken, Olten, Switzerland
› Institutsangaben
Preview

Background

Fundus flavimaculatus (FFM) is a subgroup of flecked retina syndrome, characterized by yellowish-white fishtail-like flecks of lipofuscin-like material, scattered diffusely throughout the fundus [1], [2]. A rare complication of FFM associated with severe vision loss is choroidal neovascularization (CNV) [3]. So far, various therapies, mainly based on photodynamic therapy (PDT), have been applied to treat this threatening condition. However, only short-term results have been published presenting varying visual outcomes [4], [5]. In this case report, the successful long-term outcome of intravitreal administration of ranibizumab (Lucentis) in a middle-aged male is described.



Publikationsverlauf

Eingereicht: 25. September 2021

Angenommen: 06. Februar 2022

Artikel online veröffentlicht:
26. April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany